|
125 Companies |
|
183 Products |
|
183 Products |
|
133 Mechanisms of Action |
|
1 Trial |
|
2306 News |
|
| «12...29303132333435363738394041 |
- Trial completion: Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis (clinicaltrials.gov) - Sep 1, 2011
P4, N=80, Completed, Sponsor: University Hospital of North Norway
Active, not recruiting --> Completed
- ozanezumab (GSK 1223249) / GSK
New P1 trial: NOGO-A in Multiple Sclerosis FTIH (clinicaltrials.gov) - Aug 25, 2011
P1, N=3, Terminated, Sponsor: GlaxoSmithKline
- | dexpramipexole (KNS-760704) / Knopp Biosciences, Biogen
New P1 trial: Dexpramipexole Renal PK Study (clinicaltrials.gov) - Aug 24, 2011
P1, N=36, Completed, Sponsor: Biogen Idec
- ||||| New P4 trial: Fingolimod -Response According to Coping - Evaluation (clinicaltrials.gov) - Aug 17, 2011
P4, N=189, Completed, Sponsor: Novartis Pharmaceuticals
- oxycodone controlled release / Generic mfg., lidocaine 5% / Generic mfg.
Enrollment change: Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis (clinicaltrials.gov) - Aug 16, 2011
P4, N=19, Terminated, Sponsor: University of Rochester
Active, not recruiting --> Completed N=60 --> 19
- |||||||||| Betaseron (IFN-β-1b) / Bayer
New P2/3 trial: Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (clinicaltrials.gov) - Aug 15, 2011
P2/3, N=70, Completed, Sponsor: University of Turku
- |||| firategrast (SB683699) / GSK
Trial completion: Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS) (clinicaltrials.gov) - Aug 11, 2011
P2, N=343, Completed, Sponsor: GlaxoSmithKline
N=60 --> 19 Recruiting --> Completed
- Enrollment change: Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS) (clinicaltrials.gov) - Aug 10, 2011
P=N/A, N=10, Completed, Sponsor: Hicks, Audrey, Ph.D.
Recruiting --> Completed N=20 --> 10
- |||||||||| Tysabri (natalizumab) / Biogen, Royalty
New P3 trial: ASCEND: A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis (clinicaltrials.gov) - Aug 10, 2011
P3, N=856, Active, not recruiting, Sponsor: Biogen Idec
- Trial completion: Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS) (clinicaltrials.gov) - Aug 10, 2011
P=N/A, N=10, Completed, Sponsor: Hicks, Audrey, Ph.D.
N=20 --> 10 Recruiting --> Completed
- Trial completion: Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking? (clinicaltrials.gov) - Aug 10, 2011
P=N/A, N=28, Completed, Sponsor: St. Olavs Hospital
Recruiting --> Completed Recruiting --> Completed
- | GSK 2018682 / GSK
New P1 trial: Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers (clinicaltrials.gov) - Aug 10, 2011
P1, N=40, Completed, Sponsor: GlaxoSmithKline
- ||| Trial completion: Assessment of Patient Use of a New Device: RebiSmart (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=63, Completed, Sponsor: Merck KGaA
Recruiting --> Completed Active, not recruiting --> Completed
- trichuris suis ova (CNDO-201) / Fortress
New P2 trial: TRIOMS: Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome (clinicaltrials.gov) - Aug 8, 2011
P2, N=50, Recruiting, Sponsor: Charite University, Berlin, Germany
- Trial termination: Nemucough: Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders (clinicaltrials.gov) - Aug 7, 2011
P3, N=14, Terminated, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed Recruiting --> Terminated; No inclusion
- Rebif (human IFN-β-1a) / EMD Serono
Enrollment change: ReNew: Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=50, Active, not recruiting, Sponsor: Merck KGaA
Recruiting --> Terminated; No inclusion N=100 --> 50
- Enrollment change: Nemucough: Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders (clinicaltrials.gov) - Aug 7, 2011
P3, N=14, Terminated, Sponsor: Assistance Publique - Hôpitaux de Paris
N=100 --> 50 N=110 --> 14
- Rebif (human IFN-β-1a) / EMD Serono, Multiferon (interferon alpha) / SOBI, Betaseron (IFN-β-1b) / Bayer
Trial completion: REPAIR: REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients (clinicaltrials.gov) - Aug 7, 2011
P2, N=10, Completed, Sponsor: Melinda Magyari
N=110 --> 14 Recruiting --> Completed